Piperazine

These substances were identified for action under the Chemicals Management Plan (CMP).

Information sheet

Summary of publications
CAS RN DSL name Draft screening assessment Proposed conclusion on section 64 criteria Follow-up activities
110-85-0 Piperazine HTML Does not meet None planned at this time

Follow-up activities

Although a risk to human health or the environment has not been identified at current levels of exposure, there may be a concern if exposure to this substance were to increase. As a result, program officials may consider this substance in future initiatives to track its commercial status and/or any new uses.

Timelines
Date Activity
March 2022 Anticipated publication of the final screening assessment.
March 13, 2021 Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 11.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: